Cabot Past Earnings Performance
Past criteria checks 5/6
Cabot has been growing earnings at an average annual rate of 28%, while the Chemicals industry saw earnings growing at 11.8% annually. Revenues have been growing at an average rate of 7% per year. Cabot's return on equity is 32.5%, and it has net margins of 11%.
Key information
28.0%
Earnings growth rate
29.4%
EPS growth rate
| Chemicals Industry Growth | 12.4% |
| Revenue growth rate | 7.0% |
| Return on equity | 32.5% |
| Net Margin | 11.0% |
| Next Earnings Update | 06 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Cabot makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 3,924 | 433 | 260 | 59 |
| 30 Sep 23 | 3,931 | 437 | 253 | 57 |
| 30 Jun 23 | 4,078 | 300 | 242 | 57 |
| 31 Mar 23 | 4,259 | 315 | 237 | 58 |
| 31 Dec 22 | 4,318 | 348 | 246 | 55 |
| 30 Sep 22 | 4,321 | 206 | 257 | 55 |
| 30 Jun 22 | 4,113 | 142 | 290 | 56 |
| 31 Mar 22 | 3,881 | 130 | 306 | 56 |
| 31 Dec 21 | 3,631 | 98 | 297 | 55 |
| 30 Sep 21 | 3,409 | 247 | 293 | 56 |
| 30 Jun 21 | 3,164 | -54 | 315 | 57 |
| 31 Mar 21 | 2,765 | -144 | 296 | 54 |
| 31 Dec 20 | 2,633 | -219 | 292 | 57 |
| 30 Sep 20 | 2,614 | -238 | 295 | 57 |
| 30 Jun 20 | 2,782 | 65 | 246 | 54 |
| 31 Mar 20 | 3,109 | 103 | 261 | 57 |
| 31 Dec 19 | 3,243 | 127 | 268 | 58 |
| 30 Sep 19 | 3,337 | 155 | 270 | 60 |
| 30 Jun 19 | 3,360 | 217 | 281 | 65 |
| 31 Mar 19 | 3,369 | 273 | 282 | 66 |
| 31 Dec 18 | 3,343 | 77 | 295 | 67 |
| 30 Sep 18 | 3,242 | -114 | 295 | 66 |
| 30 Jun 18 | 3,115 | -136 | 282 | 64 |
| 31 Mar 18 | 2,966 | -177 | 279 | 61 |
| 31 Dec 17 | 2,826 | 69 | 263 | 59 |
| 30 Sep 17 | 2,717 | 246 | 258 | 57 |
| 30 Jun 17 | 2,613 | 225 | 270 | 53 |
| 31 Mar 17 | 2,529 | 234 | 269 | 51 |
| 31 Dec 16 | 2,419 | 209 | 264 | 49 |
| 30 Sep 16 | 2,411 | 145 | 266 | 48 |
| 30 Jun 16 | 2,463 | 136 | 251 | 49 |
| 31 Mar 16 | 2,536 | -366 | 256 | 52 |
| 31 Dec 15 | 2,662 | -388 | 263 | 54 |
| 30 Sep 15 | 2,871 | -336 | 271 | 58 |
| 30 Jun 15 | 3,111 | -348 | 281 | 58 |
| 31 Mar 15 | 3,357 | 150 | 290 | 58 |
| 31 Dec 14 | 3,561 | 160 | 303 | 60 |
| 30 Sep 14 | 3,647 | 195 | 309 | 60 |
| 30 Jun 14 | 3,632 | 214 | 304 | 65 |
| 31 Mar 14 | 3,593 | 219 | 300 | 66 |
| 31 Dec 13 | 3,534 | 212 | 296 | 65 |
| 30 Sep 13 | 3,456 | 153 | 290 | 68 |
| 30 Jun 13 | 3,408 | 142 | 286 | 68 |
Quality Earnings: CBT has high quality earnings.
Growing Profit Margin: CBT's current net profit margins (11%) are higher than last year (8.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CBT's earnings have grown significantly by 28% per year over the past 5 years.
Accelerating Growth: CBT's earnings growth over the past year (24.4%) is below its 5-year average (28% per year).
Earnings vs Industry: CBT earnings growth over the past year (24.4%) exceeded the Chemicals industry -19.4%.
Return on Equity
High ROE: CBT's Return on Equity (32.5%) is considered high.